ARCHIVES

DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects

This article is from The Cancer Letter archive.

Vol. 20 No. 24 | June 17, 1994

Download PDF Visit The Full Archive

Related Articles

Dana-Farber Correction Plan Sent To State; Pharmacy Chief Resigns

June 9, 1995

Pharmaceutical Industry: IVAX Official Broder Objects To Orphan Drug Policies of FDA

May 9, 1997

Van Nevel New NCI information Chief: Karel Leaves For Johnson Foundation

August 30, 1974

Hybridoma Cell Lines Available from NCI

September 3, 1982

In Brief: Gallo, Montagnier, Four Others Share Japan Prize; RPMI, First Cancer Center, 90 Years Old

May 20, 1988

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012